Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANVS Annovis Bio, Inc.

已收盘 03-09 16:00:00 EDT

2.57

+0.08

+3.21%

盘后2.57

+0.00+0.09%

19:49 EDT

最高2.58	最低2.41	成交量40.03万
今开2.49	昨收2.49	日振幅6.82%
总市值6,811万	流通市值5,967万	总股本2,650万
成交额100.29万	换手率1.72%	流通股本2,322万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":2.57,"timestamp":1773086400000,"preClose":2.49,"halted":0,"volume":400259,"hourTrading":{"tag":"盘后","latestPrice":2.5722,"preClose":2.57,"latestTime":"19:49 EDT","volume":5242,"amount":13476.255,"timestamp":1773100180291,"change":0.0022,"changeRate":0.000856,"amplitude":0.020311},"delay":0,"changeRate":0.032128514056224744,"floatShares":23219400,"shares":26502889,"eps":-1.441903,"marketStatus":"已收盘","change":0.08,"latestTime":"03-09 16:00:00 EDT","open":2.49,"high":2.58,"low":2.4101,"amount":1002859.5313635,"amplitude":0.068233,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.441903,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773129600000},"marketStatusCode":5,"adr":0,"listingDate":1580274000000,"exchange":"NYSE","adjPreClose":2.49,"preHourTrading":{"tag":"盘前","latestPrice":2.57,"preClose":2.49,"latestTime":"08:00 EDT","volume":1750,"amount":4454.9001,"timestamp":1773057627393,"change":0.08,"changeRate":0.032129,"amplitude":0.016064},"postHourTrading":{"tag":"盘后","latestPrice":2.5722,"preClose":2.57,"latestTime":"19:49 EDT","volume":5242,"amount":13476.255,"timestamp":1773100180291,"change":0.0022,"changeRate":0.000856,"amplitude":0.020311},"volumeRatio":1.462865,"impliedVol":1.7325,"impliedVolPercentile":0.7809},"requestUrl":"/m/hq/s/ANVS/wiki","defaultTab":"wiki","newsList":[{"id":"1194444297","title":"Annovis获DSMB批准推进阿尔茨海默病关键药物Buntanetap的三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1194444297","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194444297?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:03","pubTimestamp":1770901436,"startTime":"0","endTime":"0","summary":"Annovis Bio, Inc.近日宣布，其独立数据安全监测委员会已正式批准公司推进Buntanetap在阿尔茨海默病治疗中的关键三期临床试验。这一重要监管节点为Annovis在神经退行性疾病领域的临床开发计划扫清了道路。Annovis计划在全球多个临床中心开展这项随机、双盲、安慰剂对照的三期研究，预计将纳入约450名患者。公司强调，这一进展标志着Buntanetap成为潜在阿尔茨海默病疗法的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2608386867","title":"Annovis Bio, Inc.盘中异动 下午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608386867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608386867?lang=zh_cn&edition=full","pubTime":"2026-02-04 02:15","pubTimestamp":1770142547,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日02时15分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.19%。截至发稿，该股报2.56美元/股，成交量13.623万股，换手率0.51%，振幅8.93%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森病、阿尔茨海默病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204021547953faac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204021547953faac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2606761865","title":"Annovis Bio, Inc.盘中异动 大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606761865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606761865?lang=zh_cn&edition=full","pubTime":"2026-01-28 01:46","pubTimestamp":1769536003,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日01时46分，Annovis Bio, Inc.股票出现异动，股价急速下跌5.30%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Biomx Inc.、Briacell Therapeutics Corp C/Wts 、Hyperion Defi, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为2129.90%、754.88%、233.11%，振幅较大的相关个股有Biomx Inc.、Vyome Holdings, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为53.90%、39.87%、37.46%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森病、阿尔茨海默病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128014643953e9a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128014643953e9a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2586297553","title":"Annovis Bio, Inc.盘中异动 早盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586297553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586297553?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:35","pubTimestamp":1764167706,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日22时35分，Annovis Bio, Inc.股票出现异动，股价大幅上涨5.05%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Scisparc Ltd.、Quantum Biopharma Ltd.涨幅较大，Scisparc Ltd.、Kala Bio, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为1814.60%、155.49%、41.15%，振幅较大的相关个股有Quantum Biopharma Ltd.、Pasithea Therapeutics Corp.、Scisparc Ltd.，振幅分别为21.76%、10.89%、9.45%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森病、阿尔茨海默病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223506a7133395&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126223506a7133395&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"1182873975","title":"Annovis召开FDA会议讨论帕金森病痴呆项目；重申与FDA在关键的III期阿尔茨海默病研究上的一致性","url":"https://stock-news.laohu8.com/highlight/detail?id=1182873975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182873975?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:01","pubTimestamp":1763470874,"startTime":"0","endTime":"0","summary":"Annovis召开FDA会议，讨论帕金森病痴呆项目，同时重申与FDA在关键的III期阿尔茨海默病研究上的一致性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2584603452","title":"美国OTC市场Cosciens Biopharma Inc.盘中异动 临近收盘大幅下挫6.70%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584603452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584603452?lang=zh_cn&edition=full","pubTime":"2025-11-18 04:49","pubTimestamp":1763412574,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日04时49分，美国OTC市场Cosciens Biopharma Inc.股票出现波动，股价快速跳水6.70%。截至发稿，该股报2.09美元/股，成交量515股，换手率0.02%，振幅0.45%。美国OTC市场Cosciens Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.38%。美国OTC市场Cosciens Biopharma Inc.公司简介：依特钠有限公司是一家生物制药公司，为医疗保健和化妆品行业开发和商业化多样化的制药和诊断产品以及活性成分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118044934a7001592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118044934a7001592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139","CSCIF"],"gpt_icon":0},{"id":"1126228261","title":"Annovis公布新生物标志物数据，揭示类淀粉共病与帕金森患者认知能力加速下降之间的关联","url":"https://stock-news.laohu8.com/highlight/detail?id=1126228261","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126228261?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:02","pubTimestamp":1763384533,"startTime":"0","endTime":"0","summary":"Annovis公布的新生物标志物数据显示，类淀粉共病与帕金森患者的认知能力加速下降存在关联。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"1182754629","title":"Annovis宣布以市场价格进行340万美元的普通股注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1182754629","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182754629?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:02","pubTimestamp":1761566555,"startTime":"0","endTime":"0","summary":"Annovis宣布以市场价格进行340万美元的普通股注册直接发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2575971582","title":"Annovis Bio, Inc.盘中异动 大幅拉升5.06%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575971582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575971582?lang=zh_cn&edition=full","pubTime":"2025-10-16 00:04","pubTimestamp":1760544252,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日00时04分，Annovis Bio, Inc.股票出现异动，股价急速上涨5.06%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Genprex, Inc.、奥麦罗制药、Theriva Biologics, Inc.涨幅较大，Genprex, Inc.、Theriva Biologics, Inc.、Scisparc Ltd.较为活跃，换手率分别为1685.81%、812.03%、121.63%，振幅较大的相关个股有Genprex, Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博，振幅分别为255.05%、156.54%、129.49%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森病、阿尔茨海默病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016000412a461aff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016000412a461aff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2575218932","title":"Annovis Bio, Inc.盘中异动 快速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575218932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575218932?lang=zh_cn&edition=full","pubTime":"2025-10-14 03:01","pubTimestamp":1760382105,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日03时01分，Annovis Bio, Inc.股票出现异动，股价大幅下挫5.29%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森病、阿尔茨海默病和其他神经退行性疾病的药物。消息层面，截至03时01分，《Maxim Group维持Annovis Bio买入评级，维持目标价8美元》资讯为影响Annovis Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014030145972bc5b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014030145972bc5b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"1110401784","title":"Annovis Bio公布阿尔茨海默病患者新生物标志物数据，支持Buntanetap作为疾病修饰性治疗的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1110401784","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110401784?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:42","pubTimestamp":1760010168,"startTime":"0","endTime":"0","summary":"Annovis Bio公布阿尔茨海默病患者新生物标志物数据，支持Buntanetap作为疾病修饰性治疗的潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2518797452","title":"Annovis Bio, Inc.盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518797452?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:12","pubTimestamp":1741619549,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时12分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.17%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3572.82%、955.62%、797.28%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231229abf32185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231229abf32185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2517916971","title":"Annovis Bio, Inc.盘中异动 下午盘快速下挫5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517916971?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:47","pubTimestamp":1741286878,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时47分，Annovis Bio, Inc.股票出现波动，股价急速跳水5.33%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307024758963c7a56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307024758963c7a56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2516654300","title":"Annovis Bio, Inc.盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654300?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:13","pubTimestamp":1741025581,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时13分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.46%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021301abe67433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021301abe67433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2514633891","title":"Annovis Bio, Inc.盘中异动 股价大涨5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514633891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514633891?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:04","pubTimestamp":1740675841,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时04分，Annovis Bio, Inc.股票出现波动，股价大幅拉升5.17%。截至发稿，该股报1.83美元/股，成交量25.9938万股，换手率1.33%，振幅4.89%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280104019632cf9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280104019632cf9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2514184270","title":"Annovis Bio, Inc.盘中异动 早盘快速跳水5.33%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514184270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514184270?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494663,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.33%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224424a2538a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224424a2538a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2514737897","title":"Annovis Bio, Inc.盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514737897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514737897?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:48","pubTimestamp":1740412113,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时48分，Annovis Bio, Inc.股票出现异动，股价大幅下挫5.00%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234834abdb2022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234834abdb2022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2513213728","title":"Annovis Bio, Inc.盘中异动 股价大跌5.05%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513213728?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:59","pubTimestamp":1740160745,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时59分，Annovis Bio, Inc.股票出现波动，股价快速下跌5.05%。截至发稿，该股报2.12美元/股，成交量21.8575万股，换手率1.12%，振幅6.44%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015905962ba9b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015905962ba9b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2512488293","title":"Annovis Bio, Inc.盘中异动 股价大跌6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512488293?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:33","pubTimestamp":1739975584,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时33分，Annovis Bio, Inc.股票出现异动，股价快速跳水6.45%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223305a24bf9ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223305a24bf9ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2511690164","title":"Annovis Bio, Inc.盘中异动 临近午盘急速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511690164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511690164?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:00","pubTimestamp":1739552451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时00分，Annovis Bio, Inc.股票出现波动，股价急速拉升5.38%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215010051abcf26ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215010051abcf26ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":-0.0709},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.4527},{"period":"6month","weight":0.0873},{"period":"1year","weight":0.4561},{"period":"ytd","weight":-0.2803}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0201},{"period":"3month","weight":-0.0194},{"period":"6month","weight":0.0388},{"period":"1year","weight":0.174},{"period":"ytd","weight":-0.014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annovis Bio, Inc.于2008年4月29日根据特拉华州法律注册成立。Annovis是一家临床阶段制药公司，专注于开发和商业化用于治疗帕金森氏症（“PD”）和阿尔茨海默氏症（“AD”）疾病以及神经退行性疾病的创新药物。该公司的先导化合物ANVS-401是一种神经化学神经缺陷疗法，可抑制神经变性并抑制神经毒性蛋白质转化为成人和正常化的轴突囊泡转运。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.040659},{"month":2,"riseRate":0.285714,"avgChangeRate":0.058949},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.042257},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.134852},{"month":5,"riseRate":0.666667,"avgChangeRate":0.302491},{"month":6,"riseRate":0.5,"avgChangeRate":0.167707},{"month":7,"riseRate":0.666667,"avgChangeRate":0.098191},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.070358},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.058484},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.073043},{"month":11,"riseRate":0.666667,"avgChangeRate":0.26823},{"month":12,"riseRate":0.333333,"avgChangeRate":0.124011}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}